Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Benitec Biopharma Ltd ADR (Sponsored) (New) BTEBY

Recent & Breaking News (GREY:BTEBY)

Benitec in-licenses clinical program for head and neck cancer from NantWorks

PR Newswire December 23, 2016

Benitec releases pivotal data in an in vivo hepatitis B model

PR Newswire December 20, 2016

Benitec initiates a strategic engagement with NantVentures

PR Newswire October 24, 2016

Benitec Biopharma Interim Report for the Nine Months Ended March 31, 2016

PR Newswire May 24, 2016

Benitec Biopharma to Host Corporate Update Conference Call

PR Newswire May 17, 2016

Benitec to present at the ASGCT 2016 Annual Meeting

PR Newswire April 25, 2016

Benitec's Hepatitis B Therapy Reduces HBV DNA by 98.5% In Vivo

PR Newswire March 8, 2016

Benitec Biopharma Limited: Interim Report for the Half Year Ended December 31, 2015

PR Newswire February 25, 2016

Update on TT-034 Hepatitis C Clinical Trial

PR Newswire February 25, 2016

Benitec Biopharma to Host Corporate Update Conference Call

PR Newswire December 10, 2015

Greg West, Benitec's Chief Financial Officer and Company Secretary, Named Interim Chief Executive Officer

PR Newswire December 8, 2015

Benitec's Hepatitis B Therapeutic Shows Positive Preclinical Results

PR Newswire December 7, 2015

Benitec Biopharma's Abstract Accepted for Presentation at the AASLD Liver Meeting 2015

PR Newswire October 22, 2015

Benitec Forms Hepatology Clinical Advisory Board

PR Newswire October 19, 2015

Benitec Biopharma to Present at The 14th Annual BIO Investor Forum

PR Newswire October 14, 2015

Lonza and Benitec Enter Agreement to Develop Scalable AAV Manufacturing Process for ddRNAi Therapeutics

PR Newswire October 7, 2015

Benitec Biopharma Limited (Nasdaq: BNTC) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire September 24, 2015

Benitec Featured at CHI's "Discovery On Target" Conference

PR Newswire September 23, 2015

Benitec Initiates a Fourth Site in Hepatitis C Clinical Trial

PR Newswire September 16, 2015

Benitec Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ

PR Newswire August 24, 2015